Advertisement
News
Subscribe to MDT Magazine News

Disparities 2010: Interview with Charles M. Perou, Ph.D.

October 1, 2010 12:32 pm | by AACR | Comments

Disparities 2010: Interview with Charles M. Perou, Ph.D., professor of genetics, pathology and laboratory medicine, University of North Carolina, Chapel Hill

TOPICS:

Disparities 2010: Interview with William G. Nelson, M.D., Ph.D.

October 1, 2010 12:31 pm | by AACR | Comments

Dr. Nelson discusses the most common cancer disparity among men, his activity on AACR’s new survivorship research task force, and his experience reviewing the exciting research proposals for Stand Up To Cancer in this wide-ranging interview.

TOPICS:

Laning takes director role at Human Stem Cell Bank and Registry

October 1, 2010 10:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Joseph Laning, a former senior director of cell and analytical biology at ViaCell Inc., has been appointed senior director of the Human Stem Cell Bank and Registry at the University of Massachusetts Medical School.

Advertisement

Mass. drug companies drawing Japanese interest

October 1, 2010 9:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Massachusetts life sciences companies are increasingly attracting the attention of Japanese firms. The sale of Marlborough-based Sepracor Inc. to Japanese drug maker Dainippon Sumitomo Pharma will be completed this quarter, marking the second Japanese purchase of a large local...

TOPICS:

Scientists discover way to mass-produce cancer drug

October 1, 2010 9:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Researchers at MIT, in collaboration with Tufts University, have discovered a new means of using E. coli bacteria to produce, in larger quantities potentially for less money, a compound used in the production of the cancer drug Taxol.

NCPA: Walmart Medicare Drug Plan a Prescription for Poor Pharmacy Care

October 1, 2010 9:33 am | by Bio-Medicine.Org | Comments

ALEXANDRIA, Va., Oct. 1 /PRNewswire-USNewswire/ -- Wal-Mart Stores, Inc., the world's largest corporation, today announced a Medicare prescription drug plan that imposes higher co-payments on seniors who choose to continue using their trusted local, community pharmacy. (Logo:...

TOPICS:

Best Practices, LLC Research Highlights Evolving Role of Market Research in Organizational Success

October 1, 2010 9:33 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C., Oct. 1 /- The pharmaceutical and biotechnology sectors have long turned to the market research function to help organizations navigate the competitive landscape. As the marketplace has evolved, leading organizations have learned that the market research function needs...

TOPICS:

New National Program to Study and Establish Pediatric Dosing

October 1, 2010 9:33 am | by Bio-Medicine.Org | Comments

KANSAS CITY, Mo., Oct. 1 /- A new national initiative, the Pediatric Trials Network (PTN), was created this week with a $95 million grant supported by the National Institutes of Health (NIH).  The PTN will be led through collaboration between the Eunice Kennedy Shriver National...

TOPICS:
Advertisement

New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease

October 1, 2010 9:33 am | by Bio-Medicine.Org | Comments

FORT LEE, N.J., Oct. 1 /- Neurologix, Inc. (OTC Bulletin Board: NRGX ), today announced that new details of the company's landmark, randomized, double-blind Phase 2 clinical trial of NLX-P101, its investigational gene therapy for advanced Parkinson's disease (PD), were presented during a...

TOPICS:

CVS Caremark Recognizes Its 26,000 Pharmacists During October's American Pharmacists Month

October 1, 2010 9:33 am | by Bio-Medicine.Org | Comments

WOONSOCKET, R.I., Oct. 1 /- October is American Pharmacists Month and CVS Caremark is recognizing its 26,000 pharmacists who provide outstanding care to their patients every day in its retail pharmacies, mail service pharmacies and specialty pharmacies across the country. (Logo:...

TOPICS:

DMC Sinai-Grace Selects Loopback Communications' Readmission Reduction™ Services

October 1, 2010 9:33 am | by Bio-Medicine.Org | Comments

DALLAS, Oct. 1 /- DMC Sinai-Grace Hospital has selected Dallas-based Loopback Communications' technology-leading Readmission Reduction™ solution to support its efforts to reduce readmissions of discharged patients. "DMC Sinai-Grace is committed to continuous quality improvement and...

TOPICS:

Disparities 2010: Interview with Howard K. Koh, M.D., M.P.H

October 1, 2010 9:32 am | by AACR | Comments

Disparities 2010: Interview with Howard K. Koh, M.D., M.P.H., assistant secretary for health, U.S. Department of Health and Human Services

TOPICS:

Health Management acquires 2 Florida hospitals

October 1, 2010 8:45 am | by The Associated Press | Comments

Health Management Associates acquired Wuesthoff Health System, which runs two hospitals in eastern Florida, for $152 million.The hospital operator said Friday that Wuesthoff runs one hospital in Rockledge with 298 beds, and one in Melbourne with 115 beds. It said the deal is effective Friday....

Stocks waver after data shows growth remains slow

October 1, 2010 7:45 am | by STEPHEN BERNARD - AP Business Writer - Associated Press | Comments

Signs of slowing growth in manufacturing kept investors' enthusiasm in check Friday as the final quarter of the year got under way.The Dow Jones industrial average rose 22 points in late morning trading after the Institute for Supply Management said its manufacturing index fell modestly in...

Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet

October 1, 2010 7:34 am | by Bio-Medicine.Org | Comments

BRIDGEWATER, N.J., Oct. 1 /- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) announced today that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S. Food and Drug Administration (FDA) approval of Jevtana® (cabazitaxel) Injection, was published in the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading